- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 33/08 - Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
Patent holdings for IPC class A61P 33/08
Total number of patents in this class: 7
10-year publication summary
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ono Pharmaceutical Co., Ltd. | 431 |
2 |
| AstraZeneca AB | 2933 |
1 |
| Astellas Pharma Inc. | 1086 |
1 |
| Dainippon Sumitomo Pharma Co., Ltd. | 195 |
1 |
| IPCA Laboratories Limited | 33 |
1 |
| Kyoto University | 2796 |
1 |
| Other owners | 0 |